Open access
106
Views
5
CrossRef citations to date
0
Altmetric
Original Research
Levodopa/carbidopa/entacapone versus levodopa/dopa-decarboxyiase inhibitor for the treatment of Parkinson’s disease: systematic review, meta-analysis, and economic evaluation
Zhan-Miao Yi1 Department of Pharmacy, Peking University Third Hospital;2 Department of Pharmacy Administration and Clinical Pharmacy, Peking University School of Pharmaceutical Science;3 Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China
, Ting-Ting Qiu1 Department of Pharmacy, Peking University Third Hospital;4 Public Health Department, Aix-Marseille University, Marseille, France
, Yuan Zhang5 Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, ON, Canada
, Na Liu6 Department of Neurology, Peking University Third Hospital, Beijing, China
& Suo-Di Zhai1 Department of Pharmacy, Peking University Third Hospital;3 Institute for Drug Evaluation, Peking University Health Science Center, Beijing, ChinaCorrespondence[email protected]
Pages 709-719
|
Published online: 16 Apr 2018
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.